GNLY and Alzheimer disease: We also observed a decrease in cytotoxicity genes (FCER1G, CTSW, GZMB, GNLY, KLRF1, SPON2, FGFBP2, and PRF1) and activation markers (CD69 and KLRB1) in NK cells from patients with AD (Figure 2E).